Ganglion blocking drugs are no longer used in therapeutics because:
A. They have few and weak pharmacological
actions
B. They produce many side effects
C. They are inactive by oral route
D. They have short duration of action
A. They have few and weak pharmacological
actions
B. They produce many side effects
C. They are inactive by oral route
D. They have short duration of action